Evaxion Biotech
Evaxion Biotech is a Denmark-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed Evaxion Biotech Information
Geographic Data
Address: Bredgade 34E
City: Copenhagen
State: capital region
Zip: 1260
Country: DK
Financial Info
Stage:
post ipo equity
Raised Last:
$40M
Raised Total:$57M
Social
Metrics
6,694,589Website Global Rank
867Website Monthly Traffic
Twitter Followers
Description
Evaxion Biotech is a Denmark-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer and infectious diseases.
Contact Phone:
Contact Email:
Evaxion Biotech went public on 2/4/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/4/2021
Ticker Symbol:
EVAX
IPO Price:
$10/share
Amount Raised:
$30M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2019 | Venture Round | $17M | 9/2022 | Grant | 1 | - |
National Institutes of Health National Institutes of Health |
2/2021 | IPO | $30M | 6/2022 | Post-IPO Equity | 1 | $40M |
Lincoln Park Capital Fund Lincoln Park Capital Fund |
12/2017 | Grant | $3M |
Innovation Fund Denmark |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
